Sign in
Not yet recruitingPhase 3

Comparative Study of Post-Varicocelectomy Myo-inositol vs. Antioxidants vs. Surgery Alone in Infertile Men

Key facts

Who runs it
Fayoum University Hospital
Where
Egypt1 site in 1 countryChoose a country to see its sites
Trial code
Status
Not yet recruiting
Phase
Phase 3
People taking part
150 people, planned
Started
26 Oct 2026
Expected to end
1 Jul 2027
Type of study
Interventional, 3 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Experimental Arm Intervention: Myo-inositol
  • Conventional Antioxidants
  • Group C (Control)
Record updated
4 November 2026

Who can take part

Age
18 years to 50 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 8 criteriaShow less

Who can take part

  • Adult male patients; Clinically palpable Grade II or Grade III varicocele undergoing varicocelectomy; Presence of primary or secondary infertility; Impaired semen analysis parameters; Reduced testicular volume

Who cannot take part

  • History of previous varicocelectomy operations
  • Systemic vascular or medical diseases affecting arterial flow (e.g., diabetes mellitus, hypertension, liver disease, hypercholesterolemia)
  • Active genital tract infections
  • Pediatric (infants) or elderly populations
  • Sub-clinical varicocele
  • Hormonal abnormalities or autism
  • -

The main criteria, as questions

These questions come from the eligibility criteria published for this trial. They help you read the criteria and prepare for a talk with your doctor or the study team. We do not tell you a result. Only the study team can say whether you can take part.

  • Are you between 18 and 50 years old?

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The purpose of this open-label, 3-arm randomized controlled trial is to compare the clinical efficacy and safety of adding oral myo-inositol versus conventional oral antioxidants (vitamin C, L-carnitine, and zinc) versus surgery alone following microscopic subinguinal varicocelectomy in infertile adult males with clinical varicocele.

The 3 groups in the trial

  • Group A: Myo-inositolTreatment being tested

    Surgical Intervention: Microscopic subinguinal varicocelectomy. Drug/Supplement: Oral Myo-inositol 2g tablets, twice daily for 3 to 6 months post-surgery.

    Treatment: Experimental Arm Intervention: Myo-inositol

  • Group B: Conventional AntioxidantsExisting treatment, for comparison

    Surgical Intervention: Microscopic subinguinal varicocelectomy. Drug/Supplement: Oral Vitamin C (500mg daily) + L-Carnitine (1000mg twice daily) + Zinc (10mg twice daily) for 3 to 6 months post-surgery.

    Treatment: Conventional Antioxidants

  • Group C: Varicocelectomy AlonePlacebo, for comparison

    Microscopic subinguinal varicocelectomy alone with no adjuvant medical therapy post-surgery.

    Treatment: Group C (Control)

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Comparative Study Between Myo-inositol Add on Post Varicocelectomy Versus Add on Conventional Antioxidants or Varicocelectomy Alone in Infertile Patients
Criteria questions
Built from NCT07915388, who can take part
Record updated
4 November 2026